Clinical Trials Browser

Phase 2 × NIH × Pioglitazone × Clear all

NCT00099021 2022-02-11

Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Phase 2 Completed

21 enrolled 6 charts

Head and Neck Neoplasms, Leukoplakia, Oral

NCT01342770 2017-12-05

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Phase 2 Terminated

6 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00951379 2016-04-06

Pioglitazone for Oral Premalignant Lesions

Phase 2 Terminated

52 enrolled 23 charts

Leukoplakia, Oral

NCT00923949 2015-09-30

Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

Phase 2 Terminated

1 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung